Search research articles
Contact Us
Filters
Showing results (81-90 of 117) with videos related to
Page
of 12
Sort By:
Leukemia
|
January 1, 1994
A randomized phase II study of low-dose cytosine arabinoside (LD-AraC) plus granulocyte-macrophage colony-stimulating factor (rhGM-CSF) in myelodysplastic syndromes (MDS) with a high risk of developing leukemia. EORTC Leukemia Cooperative Group
H H Gerhartz, R Marcus, A Delmer, et al.
Nouvelle Revue Francaise D'Hematologie
|
February 1, 1993
[Comparison between intensive consolidation by bone marrow autograft or by chemotherapy of acute myeloblastic leukemias in 1st complete remission: AML8A protocol of the Leukemia Cooperative Group of the European Organization for Research and Treatment of Cancer (EORTC)]
R Zittoun, B Rio, A Delmer, et al.
Leukemia
|
October 8, 2004
FcgammaRIIB expression in diffuse large B-cell lymphomas does not alter the response to CHOP+rituximab (R-CHOP)
S Camilleri-Broët, N Mounier, A Delmer, et al.
The American Journal of Pathology
|
December 10, 1998
Homing receptor alpha4beta7 integrin expression predicts digestive tract involvement in mantle cell lymphoma
F Geissmann, A Ruskoné-Fourmestraux, O Hermine, et al.
Leukemia
|
May 1, 1994
Coexpression of anionic glutathione-S-transferase (GST pi) and multidrug resistance (mdr1) genes in acute myeloid and lymphoid leukemias
D Russo, J P Marie, D C Zhou, et al.
Leukemia & Lymphoma
|
February 27, 1999
Angioimmunoblastic-like T-cell non Hodgkin's lymphoma: outcome after chemotherapy in 33 patients and review of the literature
P Pautier, A Devidas, A Delmer, et al.
Presse Medicale (Paris, France : 1983)
|
October 26, 1988
[Antibiotic therapy protocol using ceftazidime 3g/day alone or in combination with vancomycin or amikacin. In febrile episodes in neutropenic patients]
J P Marie, J L Pico, D Chiche, et al.
Journal Francais D'Ophtalmologie
|
July 27, 1999
[Orbital lymphoma and AIDS. Apropos of a case]
T Than-Trong, X Morel, F D'Hermies, et al.
Infection
|
January 1, 1992
Treatment of myelodysplastic syndromes (MDS) and high leukaemic risk with low-dose cytosine arabinoside (LD-AraC) plus granulocyte-macrophage colony-stimulating factor (rh GM-CSF). The EORTC Leukaemia Group
H H Gerhartz, R Marcus, A Delmer, et al.
Leukemia & Lymphoma
|
October 1, 1994
Evaluation of carboplatin as a single agent in highly refractory acute myeloid leukemia
A Delmer, F Bauduer, A Vekhoff, et al.
Page
of 12
Search research articles
Search
Showing results (81-90 of 117) with videos related to
Sort By:
Page
of 12
Leukemia
|
January 1, 1994
A randomized phase II study of low-dose cytosine arabinoside (LD-AraC) plus granulocyte-macrophage colony-stimulating factor (rhGM-CSF) in myelodysplastic syndromes (MDS) with a high risk of developing leukemia. EORTC Leukemia Cooperative Group
H H Gerhartz, R Marcus, A Delmer, et al.
Nouvelle Revue Francaise D'Hematologie
|
February 1, 1993
[Comparison between intensive consolidation by bone marrow autograft or by chemotherapy of acute myeloblastic leukemias in 1st complete remission: AML8A protocol of the Leukemia Cooperative Group of the European Organization for Research and Treatment of Cancer (EORTC)]
R Zittoun, B Rio, A Delmer, et al.
Leukemia
|
October 8, 2004
FcgammaRIIB expression in diffuse large B-cell lymphomas does not alter the response to CHOP+rituximab (R-CHOP)
S Camilleri-Broët, N Mounier, A Delmer, et al.
The American Journal of Pathology
|
December 10, 1998
Homing receptor alpha4beta7 integrin expression predicts digestive tract involvement in mantle cell lymphoma
F Geissmann, A Ruskoné-Fourmestraux, O Hermine, et al.
Leukemia
|
May 1, 1994
Coexpression of anionic glutathione-S-transferase (GST pi) and multidrug resistance (mdr1) genes in acute myeloid and lymphoid leukemias
D Russo, J P Marie, D C Zhou, et al.
Leukemia & Lymphoma
|
February 27, 1999
Angioimmunoblastic-like T-cell non Hodgkin's lymphoma: outcome after chemotherapy in 33 patients and review of the literature
P Pautier, A Devidas, A Delmer, et al.
Presse Medicale (Paris, France : 1983)
|
October 26, 1988
[Antibiotic therapy protocol using ceftazidime 3g/day alone or in combination with vancomycin or amikacin. In febrile episodes in neutropenic patients]
J P Marie, J L Pico, D Chiche, et al.
Journal Francais D'Ophtalmologie
|
July 27, 1999
[Orbital lymphoma and AIDS. Apropos of a case]
T Than-Trong, X Morel, F D'Hermies, et al.
Infection
|
January 1, 1992
Treatment of myelodysplastic syndromes (MDS) and high leukaemic risk with low-dose cytosine arabinoside (LD-AraC) plus granulocyte-macrophage colony-stimulating factor (rh GM-CSF). The EORTC Leukaemia Group
H H Gerhartz, R Marcus, A Delmer, et al.
Leukemia & Lymphoma
|
October 1, 1994
Evaluation of carboplatin as a single agent in highly refractory acute myeloid leukemia
A Delmer, F Bauduer, A Vekhoff, et al.
Page
of 12